Expanded Access for Mezigdomide

Sponsor
Bristol-Myers Squibb
Study ID
NCT06994117
Status
Available

Eligibility Criteria

Sex
All
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

This is an expanded access designed to provide access to Mezigdomide for eligible participants.

Key Dates

First listed
May 29, 2025
Status verified
Dec 2025

Central Contacts

  • BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
    855-907-3286
    [email protected]
  • First line of the email MUST contain the NCT# and Site #.